1. Home
  2. UVE vs AVBP Comparison

UVE vs AVBP Comparison

Compare UVE & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UVE
  • AVBP
  • Stock Information
  • Founded
  • UVE 1990
  • AVBP 2021
  • Country
  • UVE United States
  • AVBP United States
  • Employees
  • UVE N/A
  • AVBP N/A
  • Industry
  • UVE Property-Casualty Insurers
  • AVBP
  • Sector
  • UVE Finance
  • AVBP
  • Exchange
  • UVE Nasdaq
  • AVBP NYSE
  • Market Cap
  • UVE 780.5M
  • AVBP 862.8M
  • IPO Year
  • UVE 1992
  • AVBP 2024
  • Fundamental
  • Price
  • UVE $23.64
  • AVBP $21.63
  • Analyst Decision
  • UVE
  • AVBP Strong Buy
  • Analyst Count
  • UVE 0
  • AVBP 8
  • Target Price
  • UVE N/A
  • AVBP $38.38
  • AVG Volume (30 Days)
  • UVE 278.6K
  • AVBP 484.4K
  • Earning Date
  • UVE 07-24-2025
  • AVBP 08-13-2025
  • Dividend Yield
  • UVE 3.24%
  • AVBP N/A
  • EPS Growth
  • UVE N/A
  • AVBP N/A
  • EPS
  • UVE 2.29
  • AVBP N/A
  • Revenue
  • UVE $1,547,444,000.00
  • AVBP N/A
  • Revenue This Year
  • UVE N/A
  • AVBP $85.82
  • Revenue Next Year
  • UVE $1.13
  • AVBP N/A
  • P/E Ratio
  • UVE $10.36
  • AVBP N/A
  • Revenue Growth
  • UVE 7.24
  • AVBP N/A
  • 52 Week Low
  • UVE $16.50
  • AVBP $15.47
  • 52 Week High
  • UVE $28.49
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • UVE 28.64
  • AVBP 47.74
  • Support Level
  • UVE $26.74
  • AVBP $19.71
  • Resistance Level
  • UVE $27.90
  • AVBP $22.32
  • Average True Range (ATR)
  • UVE 0.72
  • AVBP 1.32
  • MACD
  • UVE -0.40
  • AVBP -0.20
  • Stochastic Oscillator
  • UVE 4.91
  • AVBP 31.89

About UVE UNIVERSAL INSURANCE HOLDINGS INC

Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: